Back to today’s briefing

Story perspectives

Senti Bio's Cell Therapy: Hope for Leukemia Patients

4/19/2025

27 4

Summary

Story summary

Senti Bio is revolutionizing the fight against acute myeloid leukemia (AML) with groundbreaking cell therapies rooted in synthetic biology. By programming immune cells with gene circuits, they empower these cells to target cancerous cells while sparing healthy ones. Early trials are already yielding hope, with two patients celebrating complete remission, and Senti is eager to extend this life-saving technology to other cancers.

1 of 1

Story summary

Senti Bio is revolutionizing the fight against acute myeloid leukemia (AML) with groundbreaking cell therapies rooted in synthetic biology. By programming immune cells with gene circuits, they empower these cells to target cancerous cells while sparing healthy ones. Early trials are already yielding hope, with two patients celebrating complete remission, and Senti is eager to extend this life-saving technology to other cancers.